DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Franchini M, Mannucci PM.
Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
Expert Rev Hematol 2016;
9 (09) 825-830
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.